NO2849748T3 - - Google Patents
Info
- Publication number
- NO2849748T3 NO2849748T3 NO13726111A NO13726111A NO2849748T3 NO 2849748 T3 NO2849748 T3 NO 2849748T3 NO 13726111 A NO13726111 A NO 13726111A NO 13726111 A NO13726111 A NO 13726111A NO 2849748 T3 NO2849748 T3 NO 2849748T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003940 | 2012-05-18 | ||
| EP13726111.1A EP2849748B1 (en) | 2012-05-18 | 2013-05-16 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a gabapentinoid |
| PCT/EP2013/001465 WO2013170966A1 (en) | 2012-05-18 | 2013-05-16 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a gabapentinoid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2849748T3 true NO2849748T3 (es) | 2018-03-31 |
Family
ID=48539081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13726111A NO2849748T3 (es) | 2012-05-18 | 2013-05-16 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US9320725B2 (es) |
| EP (1) | EP2849748B1 (es) |
| JP (1) | JP6116673B2 (es) |
| CN (1) | CN104284658A (es) |
| AU (1) | AU2013262072B2 (es) |
| BR (1) | BR112014028574A2 (es) |
| CA (1) | CA2873624A1 (es) |
| CY (1) | CY1119777T1 (es) |
| DK (1) | DK2849748T3 (es) |
| EA (1) | EA029766B1 (es) |
| ES (1) | ES2658218T3 (es) |
| HK (1) | HK1204943A1 (es) |
| HR (1) | HRP20171708T1 (es) |
| HU (1) | HUE034659T2 (es) |
| IL (1) | IL235658A (es) |
| LT (1) | LT2849748T (es) |
| MX (1) | MX356245B (es) |
| NO (1) | NO2849748T3 (es) |
| PL (1) | PL2849748T3 (es) |
| PT (1) | PT2849748T (es) |
| RS (1) | RS56799B1 (es) |
| SI (1) | SI2849748T1 (es) |
| WO (1) | WO2013170966A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9320725B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
| US10022353B2 (en) | 2015-01-23 | 2018-07-17 | Grünenthal GmbH | Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function |
| US10449090B2 (en) | 2015-07-31 | 2019-10-22 | Allotex, Inc. | Corneal implant systems and methods |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US5708035A (en) | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
| US5472711A (en) | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| US5330761A (en) | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
| US5455046A (en) | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5399362A (en) | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
| US20030056896A1 (en) | 1995-05-12 | 2003-03-27 | Frank Jao | Effective therapy for epilepsies |
| US6117900A (en) | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| DE10252667A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| AU2003294470B2 (en) | 2002-11-26 | 2009-09-17 | Alexza Pharmaceuticals, Inc. | Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| US20040222123A1 (en) | 2003-05-06 | 2004-11-11 | Barr Laboratories, Inc. | Kit for pharmaceuticals |
| CN1245379C (zh) | 2003-10-30 | 2006-03-15 | 曹桂东 | 加巴喷丁的制法 |
| DE10360792A1 (de) | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| US20080261984A1 (en) | 2004-06-09 | 2008-10-23 | Pfizer Inc. | Use of S,S-Reboxetine in the Treatment of Pain |
| GB0412878D0 (en) | 2004-06-09 | 2004-07-14 | Pfizer Ltd | Use |
| US8093408B2 (en) | 2005-06-21 | 2012-01-10 | The Company Wockhardt | Antidepressant oral pharmaceutical compositions |
| US20080014264A1 (en) | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| DE102006046745A1 (de) | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| JP2008106028A (ja) | 2006-10-26 | 2008-05-08 | Boehringer Ingelheim Internatl Gmbh | 慢性疼痛の治療におけるフリバンセリンの使用 |
| US20080153874A1 (en) | 2006-12-22 | 2008-06-26 | Allergan Inc. | Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| WO2008108639A1 (en) | 2007-03-08 | 2008-09-12 | Avantium Holding B.V. | Co-crystalline forms of carbamazepine |
| EP1977744A1 (en) | 2007-04-03 | 2008-10-08 | Chemo Ibérica, S.A. | Polymorphic Form alpha of (S)-Pregabalin and process for its preparation |
| ATE526015T1 (de) | 2007-12-21 | 2011-10-15 | Horizon Pharma Ag | Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien |
| EP2123626A1 (en) | 2008-05-21 | 2009-11-25 | Laboratorios del Dr. Esteve S.A. | Co-crystals of duloxetine and co-crystal formers for the treatment of pain |
| EA201170356A1 (ru) | 2008-05-28 | 2011-08-30 | Плива Хрватска Д.О.О. | Полиморфные и аморфные формы лакозамида и аморфные композиции |
| WO2010025931A2 (en) * | 2008-09-05 | 2010-03-11 | Grünenthal GmbH | Pharmaceutical combination |
| DE102009013613A1 (de) | 2009-03-17 | 2010-09-23 | Ratiopharm Gmbh | Trockenverarbeitung von Retigabin |
| AU2011283462B9 (en) | 2010-07-30 | 2014-09-18 | Toray Industries, Inc. | Therapeutic agent or prophylactic agent for neuropathic pain |
| RS58017B1 (sr) * | 2010-08-04 | 2019-02-28 | Gruenenthal Gmbh | Farmaceutska dozna forma koja sadrži 6'-fluoro-(n-metil- ili n,n-dimetil-)-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano[3,4,b]indol]-4-amin za lečenje nociceptivnog bola |
| KR101882663B1 (ko) * | 2010-08-04 | 2018-07-30 | 그뤼넨탈 게엠베하 | 6’플루오로（Ｎ메틸 또는 Ｎ，Ｎ디메틸）4페닐4’，9’디하이드로3’Ｈ스피로［사이클로헥산1，1’피라노［3，4，ｂ］인돌］4아민을 포함하는 약제학적 투여형 |
| WO2012016703A2 (en) * | 2010-08-04 | 2012-02-09 | Grünenthal GmbH | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| US9320725B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid |
-
2013
- 2013-05-13 US US13/892,968 patent/US9320725B2/en active Active
- 2013-05-16 AU AU2013262072A patent/AU2013262072B2/en not_active Ceased
- 2013-05-16 NO NO13726111A patent/NO2849748T3/no unknown
- 2013-05-16 PL PL13726111T patent/PL2849748T3/pl unknown
- 2013-05-16 HU HUE13726111A patent/HUE034659T2/en unknown
- 2013-05-16 WO PCT/EP2013/001465 patent/WO2013170966A1/en active Application Filing
- 2013-05-16 MX MX2014012764A patent/MX356245B/es active IP Right Grant
- 2013-05-16 ES ES13726111.1T patent/ES2658218T3/es active Active
- 2013-05-16 PT PT137261111T patent/PT2849748T/pt unknown
- 2013-05-16 LT LTEP13726111.1T patent/LT2849748T/lt unknown
- 2013-05-16 EA EA201401268A patent/EA029766B1/ru not_active IP Right Cessation
- 2013-05-16 SI SI201330920T patent/SI2849748T1/en unknown
- 2013-05-16 EP EP13726111.1A patent/EP2849748B1/en active Active
- 2013-05-16 BR BR112014028574A patent/BR112014028574A2/pt not_active IP Right Cessation
- 2013-05-16 CN CN201380025640.1A patent/CN104284658A/zh active Pending
- 2013-05-16 JP JP2015511952A patent/JP6116673B2/ja active Active
- 2013-05-16 DK DK13726111.1T patent/DK2849748T3/en active
- 2013-05-16 RS RS20180083A patent/RS56799B1/sr unknown
- 2013-05-16 CA CA2873624A patent/CA2873624A1/en not_active Abandoned
-
2014
- 2014-11-12 IL IL235658A patent/IL235658A/en active IP Right Grant
-
2015
- 2015-06-11 HK HK15105574.6A patent/HK1204943A1/xx not_active IP Right Cessation
-
2016
- 2016-03-15 US US15/070,797 patent/US9629825B2/en active Active
-
2017
- 2017-11-08 HR HRP20171708TT patent/HRP20171708T1/hr unknown
-
2018
- 2018-01-16 CY CY20181100050T patent/CY1119777T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013262072A1 (en) | 2015-01-22 |
| US20160193183A1 (en) | 2016-07-07 |
| IL235658A0 (en) | 2015-01-29 |
| CN104284658A (zh) | 2015-01-14 |
| CY1119777T1 (el) | 2018-06-27 |
| PT2849748T (pt) | 2018-02-07 |
| EA029766B1 (ru) | 2018-05-31 |
| SI2849748T1 (en) | 2018-02-28 |
| HRP20171708T1 (hr) | 2017-12-29 |
| EP2849748B1 (en) | 2017-11-01 |
| LT2849748T (lt) | 2018-01-25 |
| EP2849748A1 (en) | 2015-03-25 |
| US9629825B2 (en) | 2017-04-25 |
| AU2013262072B2 (en) | 2018-01-18 |
| WO2013170966A1 (en) | 2013-11-21 |
| EA201401268A1 (ru) | 2015-06-30 |
| PL2849748T3 (pl) | 2018-03-30 |
| HUE034659T2 (en) | 2018-02-28 |
| IL235658A (en) | 2017-07-31 |
| US9320725B2 (en) | 2016-04-26 |
| CA2873624A1 (en) | 2013-11-21 |
| JP6116673B2 (ja) | 2017-04-19 |
| MX356245B (es) | 2018-05-21 |
| BR112014028574A2 (pt) | 2017-06-27 |
| JP2015516446A (ja) | 2015-06-11 |
| DK2849748T3 (en) | 2017-12-04 |
| HK1204943A1 (en) | 2015-12-11 |
| US20130310434A1 (en) | 2013-11-21 |
| RS56799B1 (sr) | 2018-04-30 |
| ES2658218T3 (es) | 2018-03-08 |
| MX2014012764A (es) | 2014-11-21 |